Previously, we showed that Stat3 deletion in moDCs used as a tumor vaccine enhances accumulation of effector CD8+ and CD4+ T cells, and suppresses FoxP3+ CD4+ T cell (Treg) accrual in melanoma tumors, correlating with decreased tumor growth and increased mouse survival [21]. This evidence concerns the gene CD4 and neoplasm.